Skip to main content
Premium Trial:

Request an Annual Quote

Can You Ever Just Be Whelmed?

After poking around DecodeMe's demo reference genome, VentureBeat's David Hamilton reports that the "underwhelming" service offers few useful tools for customers to learn what their SNP profile means. Users can browse through 18 genetic diseases, such as Alzheimer's disease, celiac disease, type 2 diabetes, or age-related macular degeneration, to see their risk of developing that condition -- though Hamilton warns that many of those risk estimates are only based on one SNP. Other tools predict eye or hair color and trace the user's ancestry; another lets customers share their profile with family and friends. Hamilton sums up by saying that at this point, DecodeMe "doesn’t appear to offer a heckuva lot of value for what it's charging."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.